Article Archive

Biopharma professionals reviewing contract documents to identify common CDMO agreement risks and pitfalls. — Mature FBI agents holding clipboards in hands analyzing results of field interview while having working meeting at open plan office

post

Common CDMO Contract Pitfalls (and How to Avoid Them)

Read More

Pharmaceutical vials on a production line representing the choice between CDMO outsourcing and in-house manufacturing.

post

When to Outsource Manufacturing to a CDMO vs. Build In-House

Read More

Scientist reviewing biologic drug samples and lab equipment for CDMO selection in advanced therapies.

post

Managing a CDMO Relationship: Oversight & Governance

Read More

Automated biopharma laboratory equipment supporting CDMO manufacturing for biologics and advanced therapies.

post

CDMO Selection Criteria for Biologics & Advanced Therapies

Read More

Biopharma professionals reviewing documents for potential red flags during CDMO selection.

post

CDMO Red Flags: Warning Signs to Watch in CDMO Selection

Read More

Biopharma manufacturing facility used to assess CDMO evaluation criteria, capabilities, and operational readiness.

post

CDMO Evaluation Criteria: 12 Factors to Score Before You Sign

Read More